From the Division of Female Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics and Gynecology and Urology.
University of Virginia School of Medicine, Charlottesville.
Female Pelvic Med Reconstr Surg. 2022 Jul 1;28(7):436-443. doi: 10.1097/SPV.0000000000001189. Epub 2022 May 17.
Pelvic reconstructive surgery is often associated with transient postoperative voiding dysfunction.
This study aimed to compare postoperative active voiding trial (AVT) outcomes before and after implementation of an enhanced recovery program (ERP) for women undergoing pelvic reconstructive surgery. In addition, risk factors for postoperative urinary retention were identified.
We retrospectively identified patients undergoing inpatient vaginal or robotic pelvic reconstructive surgery before and after implementation of an ERP at our institution. Demographics, operative and postoperative details, and AVT outcomes were collected. Primary outcome was AVT failure. Variables associated with increased risk of AVT failure were identified using multivariate analysis.
Three hundred seventeen patients were included-75 pre-ERP and 242 ERP. There was no difference in AVT failures between pre-ERP and ERP groups (21.3% vs 21.9%, P = 0.92). The AVT failures were highest among those with abnormal preoperative postvoid residual volume (PVR ≥100 mL, 25.9% vs 12.2%, P = 0.01) and those who underwent an incontinence procedure (midurethral sling or Kelly plication, 30.4% vs 16.9%, P = 0.01). Compared with a reference procedure (total vaginal hysterectomy [TVH]), the following procedures were associated with statistically significant higher odds ratios (ORs) of AVT failure: TVH with incontinence procedure (OR, 15.0; confidence interval [CI], 4.58-48.9; P < 0.001), TVH with anterior repair (OR, 4.98; CI, 1.93-12.9; P = 0.001), and robotic sacrocolpopexy (OR, 3.6; CI, 1.18-11.2; P = 0.02).
Postoperative AVT failure incidence did not differ pre- and post-ERP intervention. Abnormal preoperative PVR was associated with failed postoperative voiding trial. Concomitant incontinence procedures and/or anterior colporrhaphy were associated with increased incidence of voiding trial failure regardless of ERP cohort.
盆腔重建手术常伴有短暂的术后排尿功能障碍。
本研究旨在比较接受盆腔重建手术的女性在实施强化康复方案(ERP)前后的术后主动排尿试验(AVT)结果。此外,还确定了术后尿潴留的危险因素。
我们回顾性地确定了在我们机构实施 ERP 前后接受住院阴道或机器人盆腔重建手术的患者。收集了人口统计学、手术和术后细节以及 AVT 结果。主要结局是 AVT 失败。使用多变量分析确定与 AVT 失败风险增加相关的变量。
共纳入 317 例患者-ERP 前 75 例,ERP 后 242 例。ERP 前和 ERP 后组的 AVT 失败率无差异(21.3%比 21.9%,P=0.92)。术前残余尿量(PVR≥100ml)异常者 AVT 失败率最高(25.9%比 12.2%,P=0.01),且行尿失禁手术者(中尿道吊带或凯利折叠术) AVT 失败率最高(30.4%比 16.9%,P=0.01)。与参考手术(全阴道子宫切除术[TVH])相比,以下手术与 AVT 失败的统计学显著更高比值比(OR)相关:TVH 伴尿失禁手术(OR,15.0;置信区间[CI],4.58-48.9;P<0.001)、TVH 伴前修补术(OR,4.98;CI,1.93-12.9;P=0.001)和机器人骶骨阴道固定术(OR,3.6;CI,1.18-11.2;P=0.02)。
术后 AVT 失败发生率在 ERP 干预前后无差异。术前 PVR 异常与术后排尿试验失败相关。无论 ERP 队列如何,同时行尿失禁手术和/或前会阴修补术与排尿试验失败发生率增加相关。